series-b
Stage
1
Investors
About
Revatis develops multipotent adult mesenchymal stem cells using a patented technology based on minimally invasive muscle micro-biopsies for regenerative medicine and cell therapy applications in both human and veterinary health.
Explore Revatis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.